Supplementary Table S1 from Phase II Study of Palbociclib (PD-0332991) in CCND1, 2, or 3 Amplification: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1B

Authors :: Keith T. Flaherty
Alice P. Chen
Lyndsay N. Harris
Peter J. O'Dwyer
Carlos L. Arteaga
Barbara A. Conley
Ravneet Thind
Samer S. Kasbari
Mehmet S. Copur
Stanley R. Hamilton
P. Mickey Williams
David Patton
Larry V. Rubinstein
Lisa M. McShane
Victoria Wang
Robert J. Gray
Fernanda I. Arnaldez
James Zwiebel
Edith P. Mitchell
Angela M. DeMichele
Richard S. Finn
Fangxin Hong
Amy S. Clark
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Representativeness of Study Participants

Full Text Access

Tools